Lichtenheldt GmbH ads

Milan, here we come! 🇮🇹 From 6 to 8 October 2026, Lichtenheldt will be exhibiting at CPHI Milan — and this time, meeting us is easier than ever. Instead of hoping to catch the right person on the show floor, you can now book a fixed time with the specific expert you want to talk to — before the show even starts. Pick your contact, pick your slot, and you're confirmed in under a minute. Whether it's formulation, manufacturing, or a specific project you'd like to discuss — choose the person who knows that topic best, and secure your time with them directly. 📅 When? 6 to 8 October 2026 📍 Where? Stand 8F25, Fiera Milano 👤 Who? Pick your contact person 📝 Book your slot now — link below We look forward to meeting you in Milan!

Milan, here we come! 🇮🇹 From 6 to 8 October 2026, Lichtenheldt will be exhibiting at CPHI Milan. We look forward to 3 days of personal conversations, new connections and exchange about the topics currently shaping the pharmaceutical industry. Will you be in Milan too? Book a meeting with our team in advance so we can make sure there is enough time for your topics and questions. 💬 📅 When? 6 to 8 October 2026 📍 Where? Stand 8F25 🗓️ Book a meeting: https://lnkd.in/eqsN9yyv We look forward to meeting you in Milan! #cphi #pharma #cdmo #lichtenheldt

If you produce liquid or semi-solid dosage forms, sooner or later you will be faced with this decision. Should you invest - in new lines, personnel and validation? Or is it worth working with a specialized partner? Our 2026 guide provides you with clear decision-making questions, practical examples and economic considerations. Download now free of charge

CDMO projects can make or break your timelines and budgets. Hidden pitfalls, regulatory hurdles and lack of scalability are risks you can’t afford. ✅ This free guide shows you: How to spot red flags early Which questions to ask potential CDMO partners How to avoid costly delays Make your next CDMO project a success — download your free guide now.

If you produce liquid or semi-solid dosage forms, sooner or later you will be faced with this decision. Should you invest - in new lines, personnel and validation? Or is it worth working with a specialized partner? Our 2025 guide provides you with clear decision-making questions, practical examples and economic considerations. Download now free of charge

Should you invest in your own production capacity – or partner with a CDMO? For many pharmaceutical and medical device companies, that decision has never been more complex. Rising costs. Capacity constraints. Regulatory requirements. Skilled labor shortages. Our Make-or-Buy Guide 2026 helps you evaluate the key factors before making your next manufacturing decision. ✔ Capacity planning ✔ GMP & compliance considerations ✔ Cost implications ✔ Outsourcing opportunities Download your free guide today.